Skip to main content
icon for US fertility rate up in Q1 2026?

US fertility rate up in Q1 2026?

icon for US fertility rate up in Q1 2026?

US fertility rate up in Q1 2026?

27% chance
Polymarket
NEW
27% chance
Polymarket
NEW
The CDC estimates a general fertility rate of 53.3 births per 1,000 women aged 15–44 for Q4 2025 (see: https://www.cdc.gov/nchs/nvss/vsrr/natality-dashboard.htm). This market will resolve to "Yes" if the initial reported rate for Q1 2026 exceeds 53.3, according to the CDC's Vital Statistics Rapid Release series. Otherwise, this market will resolve to "No". If the CDC does not release general fertility rate data for Q1 2026 by March 31, 2027, 11:59 PM ET, this market will resolve to "No". Resolution will be based on the first published estimate for Q1 2026, regardless of any subsequent revisions. The resolution source will be the CDC’s Vital Statistics Rapid Release.Recent preliminary CDC data showing sharp year-over-year drops in January and February 2026 births—down 4.8% and 2.15% respectively—has locked in trader consensus that the U.S. general fertility rate will not rise in Q1 compared to the prior quarter's 53.3 benchmark. This continues the steady downward trajectory confirmed in April's provisional 2025 report, where the annual rate hit a record low of 53.1 births per 1,000 women aged 15-44 amid long-running cultural shifts like delayed childbearing, economic pressures, and below-replacement patterns persisting since 2007. With no reversal signals in early monthly figures, traders view an increase as unlikely, awaiting the next CDC Vital Statistics Rapid Release for final confirmation while noting the market's strong implied probability for no uptick reflects these sustained demographic headwinds.

The CDC estimates a general fertility rate of 53.3 births per 1,000 women aged 15–44 for Q4 2025 (see: https://www.cdc.gov/nchs/nvss/vsrr/natality-dashboard.htm).

This market will resolve to "Yes" if the initial reported rate for Q1 2026 exceeds 53.3, according to the CDC's Vital Statistics Rapid Release series. Otherwise, this market will resolve to "No".

If the CDC does not release general fertility rate data for Q1 2026 by March 31, 2027, 11:59 PM ET, this market will resolve to "No".

Resolution will be based on the first published estimate for Q1 2026, regardless of any subsequent revisions.

The resolution source will be the CDC’s Vital Statistics Rapid Release.
Volume
$72
End Date
Dec 31, 2026
Market Opened
Apr 27, 2026, 4:53 PM ET
The CDC estimates a general fertility rate of 53.3 births per 1,000 women aged 15–44 for Q4 2025 (see: https://www.cdc.gov/nchs/nvss/vsrr/natality-dashboard.htm). This market will resolve to "Yes" if the initial reported rate for Q1 2026 exceeds 53.3, according to the CDC's Vital Statistics Rapid Release series. Otherwise, this market will resolve to "No". If the CDC does not release general fertility rate data for Q1 2026 by March 31, 2027, 11:59 PM ET, this market will resolve to "No". Resolution will be based on the first published estimate for Q1 2026, regardless of any subsequent revisions. The resolution source will be the CDC’s Vital Statistics Rapid Release.
The CDC estimates a general fertility rate of 53.3 births per 1,000 women aged 15–44 for Q4 2025 (see: https://www.cdc.gov/nchs/nvss/vsrr/natality-dashboard.htm). This market will resolve to "Yes" if the initial reported rate for Q1 2026 exceeds 53.3, according to the CDC's Vital Statistics Rapid Release series. Otherwise, this market will resolve to "No". If the CDC does not release general fertility rate data for Q1 2026 by March 31, 2027, 11:59 PM ET, this market will resolve to "No". Resolution will be based on the first published estimate for Q1 2026, regardless of any subsequent revisions. The resolution source will be the CDC’s Vital Statistics Rapid Release.Recent preliminary CDC data showing sharp year-over-year drops in January and February 2026 births—down 4.8% and 2.15% respectively—has locked in trader consensus that the U.S. general fertility rate will not rise in Q1 compared to the prior quarter's 53.3 benchmark. This continues the steady downward trajectory confirmed in April's provisional 2025 report, where the annual rate hit a record low of 53.1 births per 1,000 women aged 15-44 amid long-running cultural shifts like delayed childbearing, economic pressures, and below-replacement patterns persisting since 2007. With no reversal signals in early monthly figures, traders view an increase as unlikely, awaiting the next CDC Vital Statistics Rapid Release for final confirmation while noting the market's strong implied probability for no uptick reflects these sustained demographic headwinds.

The CDC estimates a general fertility rate of 53.3 births per 1,000 women aged 15–44 for Q4 2025 (see: https://www.cdc.gov/nchs/nvss/vsrr/natality-dashboard.htm).

This market will resolve to "Yes" if the initial reported rate for Q1 2026 exceeds 53.3, according to the CDC's Vital Statistics Rapid Release series. Otherwise, this market will resolve to "No".

If the CDC does not release general fertility rate data for Q1 2026 by March 31, 2027, 11:59 PM ET, this market will resolve to "No".

Resolution will be based on the first published estimate for Q1 2026, regardless of any subsequent revisions.

The resolution source will be the CDC’s Vital Statistics Rapid Release.
Volume
$72
End Date
Dec 31, 2026
Market Opened
Apr 27, 2026, 4:53 PM ET
The CDC estimates a general fertility rate of 53.3 births per 1,000 women aged 15–44 for Q4 2025 (see: https://www.cdc.gov/nchs/nvss/vsrr/natality-dashboard.htm). This market will resolve to "Yes" if the initial reported rate for Q1 2026 exceeds 53.3, according to the CDC's Vital Statistics Rapid Release series. Otherwise, this market will resolve to "No". If the CDC does not release general fertility rate data for Q1 2026 by March 31, 2027, 11:59 PM ET, this market will resolve to "No". Resolution will be based on the first published estimate for Q1 2026, regardless of any subsequent revisions. The resolution source will be the CDC’s Vital Statistics Rapid Release.

Beware of external links.

Frequently Asked Questions

"US fertility rate up in Q1 2026?" is a prediction market on Polymarket where traders buy and sell "Yes" or "No" shares based on whether they believe this event will happen. The current crowd-sourced probability is 20% for "Yes." For example, if "Yes" is priced at 20¢, the market collectively assigns a 20% chance that this event will occur. These odds shift continuously as traders react to new developments and information. Shares in the correct outcome are redeemable for $1 each upon market resolution.

"US fertility rate up in Q1 2026?" is a newly created market on Polymarket, launched on Apr 27, 2026. As an early market, this is your opportunity to be among the first traders to set the odds and establish the market's initial price signals. You can also bookmark this page to track volume and trading activity as the market gains traction over time.

To trade on "US fertility rate up in Q1 2026?," simply choose whether you believe the answer is "Yes" or "No." Each side has a current price that reflects the market's implied probability. Enter your amount and click "Trade." If you buy "Yes" shares and the outcome resolves as "Yes," each share pays out $1. If it resolves as "No," your "Yes" shares pay $0. You can also sell your shares at any time before resolution if you want to lock in a profit or cut a loss.

The current probability for "US fertility rate up in Q1 2026?" is 20% for "Yes." This means the Polymarket crowd currently believes there is a 20% chance that this event will occur. These odds update in real-time based on actual trades, providing a continuously updated signal of what the market expects to happen.

The resolution rules for "US fertility rate up in Q1 2026?" define exactly what needs to happen for each outcome to be declared a winner — including the official data sources used to determine the result. You can review the complete resolution criteria in the "Rules" section on this page above the comments. We recommend reading the rules carefully before trading, as they specify the precise conditions, edge cases, and sources that govern how this market is settled.